From a biomarkers experimental point of view, these results have been confirmed in structural neuroimaging studies since increased IL-6 serum levels were associated with global brain atrophy and white matter lesions at the Magnetic Resonance Imaging in people without cognitive impairment [19,20]. The gene discussed is IL6; the disease is Brain atrophy.